Oral contraceptives increase plasma resistance against activated protein C in women with insulin-dependent diabetes mellitus

Gynecological Endocrinology

Volumn 10, Issue SUPPL. 2, 1996, Pages 159-161

  Pedersen, O D ^a,b   Petersen, K R ^c   Skouby, S O ^c   Jespersen, J ^a,b  

^a ESBJERG HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

Activated protein C resistance; Diabetes mellitus; Oral contraceptives

Indexed keywords

EID: 26244433927     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609045651     Document Type: Article

References (5)

1. Hare, J.W. (1991). Complicated diabetes complicating pregnancy. Bailliere's Clin. Obstet. Gynaecol., 5, 349-67
2. Greene, M.F., Hare, J.W., Cloherty, J.P., Benecerraf, B.R. and Soeldner, J.S. (1989). First trimester hemoglobin A1 and risk for major malformations and spontaneous abortions in diabetic pregnancy. Teratology, 39, 225-31
3. Steel, J.M. and Duncan, J.P. (1980). Contraception for the insulin dependent diabetic woman. The view from one clinic. Diabetes Care, 3, 557-60
4. Petersen, K.R., Skouby, S.O., Sidelmann, J., Mølsted-Pedersen, L. and Jespersen, J. (1994). Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus. Am. J. Obstet. Gynecol., 171, 400-5
5. Østerud, B., Robertsen, R. Åsvang, G.B. and Thijssen, F. (1994). Resistance to activated protein C is increased in women using oral contraceptives. Blood Coag. Fibrinol., 5, 853-4